- Home
- BPMC vs ACT Comparison
BPMC vs ACT Comparison
Compare BPMC & ACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- ACT
- Stock Information
- Founded
- BPMC 2008
- ACT 1981
- Country
- BPMC United States
- ACT United States
- Employees
- BPMC N/A
- ACT N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- ACT Specialty Insurers
- Sector
- BPMC Health Care
- ACT Finance
- Exchange
- BPMC Nasdaq
- ACT Nasdaq
- Market Cap
- BPMC 5.8B
- ACT 5.2B
- IPO Year
- BPMC 2015
- ACT 2021
- Fundamental
- Price
- BPMC $88.51
- ACT $34.75
- Analyst Decision
- BPMC Buy
- ACT Buy
- Analyst Count
- BPMC 22
- ACT 4
- Target Price
- BPMC $124.29
- ACT $36.50
- AVG Volume (30 Days)
- BPMC 958.8K
- ACT 203.7K
- Earning Date
- BPMC 05-01-2025
- ACT 04-30-2025
- Dividend Yield
- BPMC N/A
- ACT 2.14%
- EPS Growth
- BPMC N/A
- ACT 6.33
- EPS
- BPMC N/A
- ACT 4.37
- Revenue
- BPMC $508,824,000.00
- ACT $1,201,774,000.00
- Revenue This Year
- BPMC $45.43
- ACT $3.35
- Revenue Next Year
- BPMC $32.80
- ACT $3.78
- P/E Ratio
- BPMC N/A
- ACT $7.87
- Revenue Growth
- BPMC 104.04
- ACT 4.17
- 52 Week Low
- BPMC $80.68
- ACT $28.98
- 52 Week High
- BPMC $121.90
- ACT $37.42
- Technical
- Relative Strength Index (RSI)
- BPMC 43.04
- ACT 59.81
- Support Level
- BPMC $86.99
- ACT $33.46
- Resistance Level
- BPMC $93.04
- ACT $35.17
- Average True Range (ATR)
- BPMC 3.36
- ACT 0.63
- MACD
- BPMC 0.32
- ACT 0.11
- Stochastic Oscillator
- BPMC 29.62
- ACT 84.21
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers will be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.